BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 35999309)

  • 21. Perspective: cancer vaccines in the era of immune checkpoint blockade.
    Cebon J
    Mamm Genome; 2018 Dec; 29(11-12):703-713. PubMed ID: 30446791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.
    Nguyen TL; Choi Y; Kim J
    Adv Mater; 2019 Aug; 31(34):e1803953. PubMed ID: 30417454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer vaccines: Tumor-associated antigens
    Wagner S; Mullins CS; Linnebacher M
    World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and development of therapeutic cancer vaccines.
    Acres B; Limacher JM; Bonnefoy J
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):185-92. PubMed ID: 17436554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized approaches to active immunotherapy in cancer.
    Ophir E; Bobisse S; Coukos G; Harari A; Kandalaft LE
    Biochim Biophys Acta; 2016 Jan; 1865(1):72-82. PubMed ID: 26241169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment.
    Rodríguez Pérez Á; Campillo-Davo D; Van Tendeloo VFI; Benítez-Ribas D
    Clin Transl Oncol; 2020 Nov; 22(11):1923-1937. PubMed ID: 32266674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer vaccines.
    Butterfield LH
    BMJ; 2015 Apr; 350():h988. PubMed ID: 25904595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive imaging in cancer immunotherapy: The way to precision medicine.
    Du Y; Qi Y; Jin Z; Tian J
    Cancer Lett; 2019 Dec; 466():13-22. PubMed ID: 31499119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in cancer immunotherapies.
    Dagher OK; Schwab RD; Brookens SK; Posey AD
    Cell; 2023 Apr; 186(8):1814-1814.e1. PubMed ID: 37059073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen presenting cell/ tumor cell fusion vaccines for cancer immunotherapy.
    Browning MJ
    Hum Vaccin Immunother; 2013 Jul; 9(7):1545-8. PubMed ID: 23475129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
    Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM
    Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations.
    Gatti-Mays ME; Redman JM; Collins JM; Bilusic M
    Hum Vaccin Immunother; 2017 Nov; 13(11):2561-2574. PubMed ID: 28857666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer.
    Bendjama K; Quemeneur E
    Hum Vaccin Immunother; 2017 Sep; 13(9):1997-2003. PubMed ID: 28846477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifunctional plant virus nanoparticles in the next generation of cancer immunotherapies.
    Shahgolzari M; Dianat-Moghadam H; Fiering S
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1076-1085. PubMed ID: 34375725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taming cancer by inducing immunity via dendritic cells.
    Palucka AK; Ueno H; Fay JW; Banchereau J
    Immunol Rev; 2007 Dec; 220():129-50. PubMed ID: 17979844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?
    Dillman RO; Cornforth AN; Nistor G
    Expert Opin Biol Ther; 2013 May; 13(5):643-56. PubMed ID: 23451922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic cancer vaccines: From initial findings to prospects.
    Song Q; Zhang CD; Wu XH
    Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
    Reardon DA; Mitchell DA
    Semin Immunopathol; 2017 Feb; 39(2):225-239. PubMed ID: 28138787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer Vaccines.
    DeMaria PJ; Bilusic M
    Hematol Oncol Clin North Am; 2019 Apr; 33(2):199-214. PubMed ID: 30832995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.